Skip to content
Events

Details

Illumina will be presenting at the 13th Meeting on EXTERNAL QUALITY ASSESSMENT IN MOLECULAR PATHOLOGY​ in Napoli, Italy on the 9th-10th May 2025.
Date & Time
9 May 2025 – 10 May 2025
Location
Napoli
Italy
Europe
Topic
Oncology
This event has passed

Related Events

May 6
Illumina Innovation Days
6 May 2025 – 2 Dec 2025
Join us as we discuss new innovative technology offerings from the Illumina product pipeline and introduce our newest system – the MiSeq i100 Series.
View Event
Jun 12
108. Jahrestagung der Deutschen Gesellschaft für Pathologie
12 Jun 2025 – 16 Jun 2025
Sind Sie auf der DGP 2025? Besuchen Sie unseren Stand A04 und erfahren Sie, wie illumina die Präzisionsmedizin durch Genomics voranbringt. Ob Panel-Sequenzierung, Whole Exome Sequencing oder Whole Genome Sequencing: Tauschen Sie sich mit unseren Experten aus und erfahren Sie mehr über unseren vollständigen End-to-End Workflow von der FFPE Probe bis hin zur NGS-Dateninterpretation und Berichterstellung. #DGP2025
View Event
Jun 24
Ghent Pathology 2025
24 Jun 2025 – 26 Jun 2025
Join us at Illumina booth at Ghent Pathology 2025 and discover how our genomic solutions could support your pathology workflow.​​ ​From an expanded range of oncology assays to streamlining data interpretation and report generation.​
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.